Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: Post hoc analyses of the women's health initiative randomized controlled trial

Journal of Clinical Oncology

Volumn 29, Issue 22, 2011, Pages 3078-3084

  Tang, Jean Y ^a   Fu, Teresa ^a   LeBlanc, Erin ^b   Manson, JoAnn E ^c   Feldman, David ^a   Linos, Eleni ^a   Vitolins, Mara Z ^d   Zeitouni, Nathalie C ^e   Larson, Joseph ^f   Stefanick, Marcia L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCIUM; COLECALCIFEROL; PLACEBO; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MELANOMA; POST HOC ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SKIN CANCER; SUPPLEMENTATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; EPIDEMIOLOGY; INCIDENCE; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; RISK; RISK FACTOR; SKIN TUMOR; UNITED STATES; WOMEN'S HEALTH;

AGED; CALCIUM, DIETARY; CHOLECALCIFEROL; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MELANOMA; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME; UNITED STATES; VITAMIN D; WOMEN'S HEALTH;

EID: 80051652112     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.5967     Document Type: Article

References (51)

1. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 30:774-778, 1994 (Pubitemid 24157120)
2. Christenson LJ, Borrowman TA, Vachon CM, et al: Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294:681-690, 2005 (Pubitemid 41159287)
3. Purdue MP, Freeman LE, Anderson WF, et al: Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol 128:2905-2908, 2008
4. Linos E, Swetter SM, Cockburn MG, et al: Increasing burden of melanoma in the United States. J Invest Dermatol 129:1666-1674, 2009
5. Chen JG, Fleischer AB Jr, Smith ED, et al: Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 27:1035-1038, 2001 (Pubitemid 34019722)
6. Epstein JH: Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol 9:487-502, 1983
7. Rosso S, Zanetti R, Pippione M, et al: Parallel risk assessment of melanoma and basal cell carcinoma: Skin characteristics and sun exposure. Melanoma Res 8:573-583, 1998 (Pubitemid 29046509)
8. Rivers JK: Is there more than one road to melanoma? Lancet 363:728-730, 2004
9. Ziegler A, Jonason AS, Leffell DJ, et al: Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994
10. Giovannucci E, Liu Y, Rimm EB, et al: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459, 2006
11. Flood A, Peters U, Chatterjee N, et al: Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer Epidemiol Biomarkers Prev 14:126-132, 2005 (Pubitemid 40165292)
12. Garland C, Garland F, Gorham E, et al: The role of vitamin D in cancer prevention. Am J Public Health 96:252-261, 2006 (Pubitemid 43167123)
13. Goodwin PJ, Ennis M, Pritchard KI, et al: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27:3757-3763, 2009
14. Wallace K, Baron JA, Cole BF, et al: Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 96:921-925, 2004 (Pubitemid 38868138)
15. Lappe JM, Travers-Gustafson D, Davies KM, et al: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85:1586-1591, 2007 (Pubitemid 46890428)
16. Zinser GM, Sundberg JP, Welsh J: Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 23:2103-2109, 2002 (Pubitemid 36109123)
17. Bijlsma MF, Spek CA, Zivkovic D, et al: Repression of smoothened by patched-dependent (Pro-)vitamin D3 secretion. PLoS Biol 4:e232, 2006
18. Colston K, Colston MJ, Feldman D: 1,25-dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083-1086, 1981 (Pubitemid 11142302)
19. Seifert M, Rech M, Meineke V, et al: Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro. J Steroid Biochem Mol Biol 89-90:375-379, 2004 (Pubitemid 38844314)
20. Yudoh K, Matsuno H, Kimura T: 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. J Lab Clin Med 133:120-128, 1999 (Pubitemid 29073235)
21. Tang JY, Xiao T, Wu A, et al: Vitamin D3 inhibits hedgehog signaling and proliferation in murine basal cell carcinomas. Cancer Prev Res (Phila) 4:744-751, 2011
22. Tang J, Wu A, Paarmi N, et al: Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control 21:387-391, 2010
23. Newton-Bishop JA, Beswick S, Randerson-Moor J, et al: Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol 27:5439-5444, 2009
24. Jackson RD, LaCroix AZ, Gass M, et al: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669-683, 2006 (Pubitemid 43247138)
25. Wactawski-Wende J, Kotchen JM, Anderson GL, et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684-696, 2006 (Pubitemid 43247139)
26. Chlebowski RT, Johnson KC, Kooperberg C, et al: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100: 1581-1591, 2008
27. Jackson RD, LaCroix AZ, Cauley JA, et al: The Women's Health Initiative calcium-vitamin D trial: Overview and baseline characteristics of participants. Ann Epidemiol 13:S98-S106, 2003 (Pubitemid 37324179)
28. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine: Vitamin D, in Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, National Academies Press, 1999, pp 250-287
29. Curb JD, McTiernan A, Heckbert SR, et al: Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13:S122-S128, 2003 (Pubitemid 37324181)
30. Garland CF, Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227-231, 1980 (Pubitemid 11238851)
31. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al: The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85:649-650, 2007 (Pubitemid 46393494)
32. Canadian Cancer Society: Canadian Cancer Society announces vitaminDrecommendations. http://www.cancer.ca/canada-wide/about%20us/ media%20centre/ cw-media%20releases/cw-2007/canadian%20cancer% 20society%20announces%20vitamin%20d% 20recommendation.aspx
33. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC, National Academies Press, 2010, pp 291-340
34. Evans SR, Houghton AM, Schumaker L, et al: Vitamin D receptor and growth inhibition by 1,25- dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res 61:127-133, 1996 (Pubitemid 26066040)
35. Nurnberg B, Graber S, Gartner B, et al: Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 29:3669-3674, 2009
36. Berwick M, Armstrong BK, Ben-Porat L, et al: Sun exposure and mortality from melanoma. J Natl Cancer Inst 97:195-199, 2005 (Pubitemid 40277369)
37. Millen AE, Tucker MA, Hartge P, et al: Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13:1042-1051, 2004 (Pubitemid 38756716)
38. Weinstock MA, Stampfer MJ, Lew RA, et al: Case-control study of melanoma and dietary vitamin D: Implications for advocacy of sun protection and sunscreen use. J Invest Dermatol 98:809-811, 1992
39. Rosenberg CA, Khandekar J, Greenland P, et al: Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma. Cancer 106:654- 663, 2006
40. Efird JT, Friedman GD, Habel L, et al: Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 12:469- 475, 2002
41. Levi F, La Vecchia C, Te VC, et al: Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147:722-726, 1998 (Pubitemid 28183271)
42. Marghoob AA, Slade J, Salopek TG, et al: Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: Screening implications. Cancer 75:707-714, 1995
43. Levi F, Randimbison L, La Vecchia C, et al: Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 146:734-739, 1997 (Pubitemid 27484007)
44. Hsu J, Forbes PD, Harber LC, et al: Induction of skin tumors in hairless mice by a single exposure to UV radiation. Photochem Photobiol 21:185-188, 1975
45. Freeman SE, Hacham H, Gange RW, et al: Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci U S A 86:5605-5609, 1989 (Pubitemid 19185593)
46. Vitasa BC, Taylor HR, Strickland PT, et al: Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 65:2811-2817, 1990 (Pubitemid 20179563)
47. Kraemer KH, Lee MM, Andrews AD, et al: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: The xeroderma pigmentosum paradigm. Arch Dermatol 130:1018-1021, 1994 (Pubitemid 24255035)
48. Ming ME, Levy RM, Hoffstad OJ, et al: Validity of patient self-reported history of skin cancer. Arch Dermatol 140:730-735, 2004 (Pubitemid 38747291)
49. Colditz GA, Martin P, Stampfer MJ, et al: Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123:894-900, 1986 (Pubitemid 16049247)
50. Millen AE, Wactawski-Wende J, Pettinger M, et al: Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: The Women's Health Initiative calcium plus vitamin D clinical trial. Am J Clin Nutr 91:1324-1335, 2010
51. Engelman CD, Fingerlin TE, Langefeld CD, et al: Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93:3381-3388, 2008